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Abstract
Background: Uncontrolled hypertension is a significant health problem in the United States, even though multiple drugs exist
to effectively treat this chronic disease.
Objective: As part of a larger project developing data visualizations to support shared decision making about hypertension
treatment, we conducted a series of studies to understand how perceptions of hypertension control were impacted by data variations
inherent in the visualization of blood pressure (BP) data.
Methods: In 3 Web studies, participants (internet sample of patients with hypertension) reviewed a series of vignettes depicting
patients with hypertension; each vignette included a graph of a patient’s BP. We examined how data visualizations that varied
by BP mean and SD (Study 1), the pattern of change over time (Study 2), and the presence of extreme values (Study 3) affected
patients’ judgments about hypertension control and the need for a medication change.
Results: Participants’ judgments about hypertension control were significantly influenced by BP mean and SD (Study 1), data
trends (whether BP was increasing or decreasing over time—Study 2), and extreme values (ie, outliers—Study 3).
Conclusions: Patients’ judgment about hypertension control is influenced both by factors that are important predictors of
hypertension related-health outcomes (eg, BP mean) and factors that are not (eg, variability and outliers). This study highlights
the importance of developing data visualizations that direct attention toward clinically meaningful information.
(J Med Internet Res 2019;21(3):e11366)  doi: 10.2196/11366
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Introduction
Uncontrolled hypertension is a significant health problem; there
are 75 million adults in the United States alone with diagnosed
hypertension [1-3]. Hypertension control is an important goal
in primary care because uncontrolled hypertension is a major
risk factor for morbidity and mortality and contributes to heart
disease, stroke, and chronic kidney disease [2]. Multiple drugs
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exist that effectively treat hypertension, yet hypertension
remains uncontrolled in 46% of patients. Several national and
regional health initiatives (eg, Healthy People 2020, Million
Hearts Initiative, and Community Preventive Task Force) have
focused on improving hypertension monitoring and
management. However, despite these efforts, data from the
National Health and Nutrition Examination Survey in 2011-2014
showed no marked change in the percentage of adults with
controlled hypertension [4].
In their hypertension clinical action model, Kerr et al [5]
identified 4 factors that predict uncontrolled
hypertension—clinical uncertainty, competing
demands/prioritization, medication-related factors (eg, side
effects), and organizational factors (eg, lack of support to follow
and reassess patients). However, the primary reason for failing
to intensify medication in a clinic visit was uncertainty about
the “true” blood pressure (BP) value. When multiple BP
readings were recorded, there was often a discrepancy between
the values with some readings falling inside the goal range and
others falling outside, leading physicians and patients to question
whether the action was warranted. BP measurements that occur
both within and above the goal range can be especially
perplexing to patients, leading to difficulty in making decisions
about BP control [6-8].
To improve hypertension control in the primary care setting,
our research team has developed a data visualization tool
designed to support shared decision making about hypertension
treatment. Our tool is a visual display of the patients’ BP data
over the last 2 years that will be embedded in the electronic
health record (EHR) and will be jointly viewed by patients and
clinicians during a primary care office visit. This tool aims to
(1) reduce clinical uncertainty about BP data and hypertension
control; and (2) increase patients’ willingness to intensify their
medication or comply with standing treatment plans, with the
downstream benefit of improving hypertension control.
The data visualization tool was developed through a rapid
prototyping process in which candidate visualizations were
iteratively refined on the basis of regular feedback from patient
and physician focus groups [9]. During the prototyping process,
we concurrently conducted a series of vignette-based Web
studies to inform the development of the data visualization tool.
Previous research on the presentation of Web-based risk
communications, including interactive graphics describing the
risk of side effects for thyroid cancer treatments and EHR patient
portal displays of laboratory blood test values, demonstrates
the value of testing the effect of data visualization interventions
on gist knowledge, perceptions of risk, and judgments about
health status [10-13]. To date, no research has examined how
data visualizations of BP designed for use in the EHR impact
patients’ perceptions of risk and hypertension control. This
paper aims to report the results of 3 studies that examined how
data visualizations that varied in BP mean and SD (Study 1),
pattern of change over time (Study 2), and the presence of
extreme values (Study 3) impact patients’ judgments about
hypertension control and the need for medication change.
Methods
Study Designs
Three demographically diverse internet samples of patients with
hypertension reviewed several brief vignettes describing
fictitious patients with hypertension through Web survey; each
vignette included a graph of the patients’ BP data. All 3 studies
used a within-subjects design, where all participants reviewed
all vignettes, presented in random order, and provided judgments
about the degree of hypertension control for every
patient/vignette. The Web surveys are described below, and the
results are reported in accordance with the Checklist for
Reporting Results of Internet E-Surveys (ie, CHERRIES
checklist) [14]. The Institutional Review Board at the University
of Missouri approved all studies. The 3 studies had very similar
methodologies; therefore, we will describe their methods and
results together. All samples were recruited by Qualtrics, a
survey company that maintains an opt-in demographically
diverse internet panel that participates; details about participant
recruitment are provided below.
Each vignette described a patient who was being treated for
hypertension and included a graph of the patient’s BP data over
the past 2 years. Figure 1 presents an example of the data
visualization tool. In Study 1, 9 vignettes systematically varied
in the mean systolic BP (SBP; 130, 145, and 160 mm HG) and
BP SD (5, 15, and 25) depicted in the graph; the slope was held
constant (Multimedia Appendix 1). The mean SBP was chosen
to represent clinical cases that included examples of controlled,
uncontrolled, and borderline hypertension according to the 2014
Evidence-Based Guideline for the Management of High Blood
Pressure in Adults from the panel members appointed to the
Eighth Joint National Committee [15]. The SDs were chosen
to represent small, moderate, and large mean variability
according to published SBP values [16].
In Study 2, 6 vignettes differed in the SBP mean (130, 145, and
160 mm HG) and pattern of change over time (ie, trend or slope
of the data; increasing or decreasing), while holding the SD
constant (15 mm HG; Multimedia Appendix 2). In Study 3, we
used 10 vignettes that differed in their mean SBP (130 and 145
mm HG), presence of outliers (no outliers, 1 outlier, or 2
outliers), and positioning of those outliers (above or below the
mean; Multimedia Appendix 3).
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Figure 1. Sample visualization tool.
Outcomes
Primary outcomes were (1) perceived BP control; (2) need for
medication change; (3) subjective risk of heart attack; and (4)
subjective risk of stroke for each vignette. Perceived BP control
and need for medication change were assessed using
agree-disagree Likert scales, while the subjective likelihood of
heart attack and stroke were measured using unlikely-likely
Likert scales. In addition, we asked participants to estimate the
proportion of SBP values out of range for each vignette: “What
percentage of the patient’s systolic blood pressure values (ie,
top number) would you estimate to be out of the goal range?”
After evaluating all vignettes, participants completed the
Subjective Numeracy Scale (SNS) [17] and a Single-Item
Literacy Screener for health literacy (SILS) [18]. In addition,
participants provided demographic information (age, gender,
race/ethnicity, education, and income) and responded to 2
additional items about how often they monitor and graph their
own BP; no identifying information was collected or stored.
Web Survey
All data were collected by open Web surveys developed using
Qualtrics survey development software [19]. Informed consent,
task instructions, practice task, vignettes, and study outcomes
were all presented through a Web survey. The research team
generated vignettes, BP displays, and outcomes for the studies.
Of note, no adaptive items were used in the Web surveys.
Responses to primary outcomes described above were recorded
through slider bar. Responses to the SNS, SILS, and
demographic items were all recorded using radio buttons on the
Web survey, except age, which was recorded as free text.
Responses to all items were required. Furthermore, back buttons
on the browsers were disabled during the survey so participants
could not go back and review previous webpages or change
their responses on previous pages.
In all 3 Web surveys, participants completed one practice
vignette that included directions for the practice task and 5
practice items; this section of the Web surveys utilized 3
webpages. Each vignette and its corresponding 5 questionnaire
items (hypertension control, need for a medication change,
10-year heart attack risk, 10-year stroke risk, and percentage of
SBP values out of goal range) added 2 additional pages to each
Web survey (per vignette). The SILS and SNS scales added 9
items, and the demographic variables added 7 items to each
Web study. Furthermore, we provided a free textbox at the end
of the study for participants to share any additional feedback
on the data visualizations presented in the Web studies.
In Study 1, the Web survey included 9 vignettes; therefore,
participants completed 68 total items across 27 total webpages.
In Study 2, the Web survey included 6 vignettes; participants
completed 53 total items across 21 total webpages. In Study 3,
the Web survey included 10 vignettes; participants completed
73 total items across 29 total webpages. The presentation order
of the vignettes and their associated outcome measures was
randomized within subjects. In addition, the team pilot-tested
each Web survey themselves for functionality and usability
before the surveys were deployed.
Participant Recruitment
Qualtrics identified participants with hypertension through a
single self-reported measure: “Has your doctor ever diagnosed
you with hypertension, also known as high blood pressure?”;
similar self-report items have been used to identify patients with
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hypertension in other epidemiological studies [20,21]. Informed
consent was received from all participants after they were
apprised about the purpose of the survey and the maximum
completion time for the survey (30 minutes); participants were
also provided with the name and contact information for the
Project Director. Data for all 3 studies were collected between
May 2016 and July 2016.
We used Internet Protocol addresses and Qualtrics identification
numbers to determine unique site visitors. The survey
completion rate was 86% (51/59) for Study 1, 79% (50/63) for
Study 2, and 66% (55/83) for Study 3. All completed
questionnaires were used in the analyses.
Power and Statistical Analyses
We planned to recruit 50 patients with hypertension for each of
the 3 Web studies. The sample size was determined a priori
using G-Power [22,23] with the following data characteristics:
80% power to detect a significant effect (f=0.25) at an alpha of
.05, with a minimum correlation of .50 between repeated
measures. All outcomes were treated as continuous variables.
We examined the effects of data variations on primary and
secondary outcomes by conducting a series of multivariate
analysis of variance tests for repeated measures. Predictors
included the level of the mean SBP (all studies), SBP SD (Study
1), presence and direction of slope (Study 2), and the number
and direction of outliers (Study 3). All tests were conducted in
SPSS version 24 and R version 3.5 and were considered
statistically significant when P<.05.
Results
Participants
Across the 3 experiments, a total of 156 patients with
hypertension participated in this research. Participants were
majority female (102/156, 65.4%) and white (116/156, 74.4%),
with a mean age of 47.30 (range 19-79) years; Table 1
summarizes additional participants’ characteristics. In
accordance with the sex and gender reporting guidelines [24],
we present the data for all 3 studies disaggregated by gender in
Multimedia Appendix 4.
In contrast, when the patient had BP that was objectively well
controlled (mean 130 mm HG), the variability of the BP data
had a significant impact on judgments about hypertension
control and related health risks. For example, when the
variability was low (SD 5 mm HG), BP was considered
reasonably well controlled with little need for a medication
change, and there was a much lower perceived risk of heart
attack and stroke. In contrast, when variability in BP data was
high (SD 25 mm HG), the perception of BP control was similar
to those patients who had much higher mean (160 mm HG) BP
values. This is noteworthy because evidence suggests that BP
mean, much more than variability, is predictive of outcomes
that matter to patients [25] (ie, heart attack and stroke). The
effects of home BP variability on cardiovascular events and
mortality are based on post-hoc analyses of 2 studies that looked
at multiple indices of home BP variability [26]. The SD of BP
is highly dependent on the mean BP, and it is unclear if indices
of BP variability independent of the mean BP incrementally
predict cardiovascular mortality or total mortality beyond mean
SBP [27-29]. In addition, BP variability has unclear prognostic
significance as varying methods or indices have been used to
quantify the BP variability in all studies with no current standard
or optimal indices available to quantify the BP variability.
Patients in Study 1 were also asked to recall the percentage of
SBP values that were “out of range” (ie, exceeded 140 mm HG)
in the graph. The recall was largely inaccurate but varied
significantly by the SBP mean and SD (F4,200=8.73; P<.001;
generalized η2=0.04; Figure 2). With low variability (SD 5),
participants overestimated the percent of SBP values out of
range when hypertension was controlled (mean 130) and
underestimated the percent of SBP values out of range when
hypertension was borderline (mean 145) or uncontrolled (mean
160). The estimates of SBP values out of range were more
accurate when there was moderate to high variability in the BP
data. Figure 2 shows a jellyfish plot of error in SBP recall. Dots
above the dotted line represent participant overestimation, and
dots below represent underestimation. For each vignette, we
show the following: (1) the mean (large black dot) and 95% CI
(black line) in the center; (2) a dot plot of all data points on the
left; and (3) a kernel-density plot of the distribution of answers
on the right.
Study 1—Variations in SBP Mean and Variability
In Study 1, we observed a significant interaction between the
SBP mean and SBP SD on perceived BP control (F4,200=16.94;
P<.001; generalized η2=0.08), need for medication change
(F4,200=16.19; P<.001; generalized η2=0.08), heart attack risk
(F4,200=8.88; P<.001; generalized η2=0.04), and stroke risk
(F4,200=11.70; P<.001; generalized η2=0.05; see Tables 2 and
3). When the mean SBP was high (160 mm HG), variability in
the BP data did not impact the perception of BP control. Across
all 3 SDs, participants reported that hypertension was not well
controlled, patients should change their medication, and patients
had an elevated risk of heart attack and stroke.
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Table 1.
Study 3, (n=53)Study 2, (n=50)Study 1, (n=51)Characteristics
18 (33)17 (34)19 (36)Gender, male, n (%)
Age (years)
50.2 (14.5)44.7 (13.6)47.0 (13.1)Mean (SD)
19-7720-7919-72Range
Race or ethnicity, n (%)
38 (69)34 (68)44 (86)White or Caucasian
9 (16)10 (20)3 (6)Black or African American
3 (5)1 (2)2 (4)Asian or Pacific Islander
1 (2)1 (2)0American Indian or Alaskan Native
2 (4)3 (6)2 (4)Hispanic or Latino/a
2 (4)1 (2)0Other
2.0 (0.9)1.8 (0.8)2.0 (1.0)Single-Item Literacy Screener for health literacy, mean (SD)
4.3 (1.0)4.3 (1.1)4.3 (0.9)Subjective Numeracy Scale, mean (SD)
Education, n (%)
2 (4)1 (2)1 (2)Some high school
13 (24)14 (28)10 (20)High school graduate
16 (29)12 (24)16 (32)Some college
4 (7)7 (14)4 (8)Vocational training
7 (13)6 (12)4 (8)Associate’s degree
8 (15)5 (10)9 (18)Bachelor’s degree
4 (7)3 (6)0Master’s degree
01 (2)5 (10)Professional degree
1 (2)1 (2)1 (2)Doctoral degree
Income (US $), n (%)
1 (2)1 (2)5 (10)<10k
6 (11)7 (14)4 (8)10-19k
13 (24)7 (14)7 (13)20-29k
10 (18)7 (14)5 (10)30-39k
5 (9)4 (8)9 (17)40-49k
8 (15)9 (18)4 (8)50-59k
2 (4)5 (10)4 (8)60-69k
3 (5)03 (6)70-79k
4 (7)2 (4)2 (4)80-89k
02 (4)1 (2)90-99k
1 (2)5 (10)6 (12)100-149k
2 (4)1 (2)1 (2)>149k
How often do you monitor your BP at home?, n (%)
8 (15)7 (14)11 (22)Never
4 (7)4 (8)4 (8)Annually
14 (25)19 (38)13 (25)Monthly
21 (38)12 (24)9 (18)Weekly
8 (15)8 (16)14 (27)Daily
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Study 3, (n=53)Study 2, (n=50)Study 1, (n=51)Characteristics
How often do you graph your home BP measurements?, n (%)
33 (60)32 (64)29 (57)Never
3 (5)3 (6)4 (8)Annually
9 (16)6 (12)6 (12)Monthly
7 (13)7 (14)6 (12)Weekly
3 (5)2 (4)6 (12)Daily
Table 2. Results of Study 1—blood pressure control.
SD 25, mean (95%
CI)
SD 15, mean (95%
CI)
SD 5, mean (95%
CI)
Level of agreement with the following statements
(0 “Strongly Disagree”-100 “Strongly Agree”)
This patient’s blood pressure is well controlled
29.18 (21.47-
36.88)
56.82 (48.87-
64.78)
79.37 (73.38-
85.36)
Mean BPa,b=130
21.8 (13.85-29.76)23.45 (15.97-
30.93)
39.57 (30.80-
48.33)
Mean BP=145
17.57 (10.28-
24.85)
16.61 (9.44-23.77)22.75 (14.51-
30.98)
Mean BP=160
This patient needs to change their medication
71.27 (63.31-
79.24)
47.39 (39.46-
55.32)
29.75 (21.41-
38.12)
Mean BP=130
85.04 (79.42-
90.66)
76.53 (69.19-
83.87)
58.16 (49.39-
66.92)
Mean BP=145
83.43 (76.12-
90.74)
85.25 (78.51-
92.00)
86.47 (80.52-
92.42)
Mean BP=160
aBP: blood pressure.
bAll BPs provided in mm HG.
Study 2—Data Trends
In Study 2, we observed that patient ratings of hypertension
control, need for medication changes, and 10-year risk of heart
attack and stroke were significantly affected by trends visible
in the BP data (see Tables 4 and 5) . Participants judged a
positive data trend (depicting SBP values increasing over time)
to be significantly less well controlled (F1,49=107.53; P<.001;
generalized η2=0.45), in greater need of medication change
(F1,49=129.07; P<.001; generalized η2=0.51), and at greater
10-year risk for a heart attack (F1,49=112.79; P<.001; generalized
η2=0.47) and stroke (F1,49=111.52; P<.001; generalized
η2=0.47) than a negative data trend (depicting SBP values
decreasing over time) with the same SBP mean. Consistent with
Study 1, participants’ recall of the percentage of SBP
measurements out of range was largely inaccurate (Figure 3).
Although the graphs depicting an increasing and decreasing
trend had the same number of out-of-range measurements,
participants recalled seeing a greater percentage of out-of-range
values when the SBP was increasing over time than when the
slope was decreasing (F1,49=33.04; P<.001; generalized
η2=0.16).
Study 3—Outliers
Another way of examining the effect of variability in judgments
about BP control is to consider the presence of extreme values
(ie, outliers) independent of the overall measurement variance.
In Study 3, we compared judgments about uniform data patterns
(ie, no discernable outliers) with those with either 1 or 2 outliers.
In addition, we systematically varied whether those outliers
were above or below the mean BP of the depicted time period.
The presence and number of outliers significantly affected
judgments of hypertension control (F4, 216=17.98; P<.001;
generalized η2=0.14), need for medication change (F4,216=13.38;
P<.001; generalized η2=0.11), and perceived risk of heart attack
(F4,216=12.85; P<.001; generalized η2=0.10), and stroke
(F4,216=13.81; P<.001; generalized η2=0.11; Tables 6 and 7).
When any extreme values were present, participants judged the
patient to have hypertension that was significantly less well
controlled, to be in greater need of medication change, and to
be at greater 10-year risk for a heart attack or stroke than when
the data had a more uniform distribution. Furthermore, 2 outliers
(whether above or below the mean) were considered
significantly more concerning than a single outlier.
Finally, recall for the percent of SBP values out of range was
also significantly impacted by the presence and magnitude of
J Med Internet Res 2019 | vol. 21 | iss. 3 | e11366 | p. 6https://www.jmir.org/2019/3/e11366/
(page number not for citation purposes)
Shaffer et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
extreme values (F4,216=5.54; P<.001; generalized η2=0.04;
Figure 4). When hypertension was controlled (mean 130),
participants overestimated the percent of SBP values out of
range with a uniform distribution and outlier(s) above the mean
but more accurately recalled the percent of SBP values out of
range when the outlier(s) were below the mean. In contrast,
with borderline hypertension control (mean 145), recall for
percent of SBP values out of range was fairly accurate with a
uniform distribution and when there was only one outlier above
the mean. However, participants consistently underestimated
the percent of SBP values out of range when there was a single
outlier below the mean or 2 outliers in either direction.
Table 3. Results of Study 1—risk perception and recall.
SD 25, mean (95% CI)SD 15, mean (95% CI)SD 5, mean (95% CI)Perceived likelihood of the following events
(1 “Extremely Unlikely”-10 “Extremely Likely”)
Heart attack in the next 10 years
6.33 (5.73-6.94)4.29 (3.67-4.92)3.82 (3.26-4.39)Mean BPa,b=130
7.61 (7.09-8.13)7.22 (6.57-7.86)5.59 (4.90-6.27)Mean BP=145
8.12 (7.65-8.59)7.98 (7.32-8.64)7.67 (7.05-8.28)Mean BP=160
Stroke in the next 10 years
6.63 (5.95-7.30)4.45 (3.77-5.13)3.76 (3.17-4.36)Mean BP=130
8.00 (7.45-8.62)7.43 (6.84-8.03)5.76 (5.08-6.45)Mean BP=145
8.35 (7.91-8.80)8.14 (7.49-8.78)8.04 (7.45-8.62)Mean BP=160
% of systolic blood pressure points out of range (0%-100%)
40400Mean BP=130 (Actual)
51.06 (44.01-58.10)38.53 (30.83-46.23)26.84 (17.98-35.71)Mean BP=130 (Recalled)
606090Mean BP=145 (Actual)
67.63 (61.69-73.57)64.08 (57.12-71.04)61.84 (53.10-70.59)Mean BP=145 (Recalled)
7090100Mean BP=160 (Actual)
71.63 (65.24-78.02)77.42 (69.45-85.42)79.78 (72.17-87.39)Mean BP=160 (Recalled)
aBP: blood pressure.
bAll BPs provided in mm HG.
Figure 2. Error in the systolic blood pressure recall—Study 1, mean (large black dot) 95% CI.
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Table 4. Results of Study 2—blood pressure control.
Decreasing, mean (95% CI)Increasing, mean (95% CI)Level of agreement with the following statements
(0 “Strongly Disagree”-100 “Strongly Agree”)
This patient’s blood pressure is well controlled
85.72 (79.2-92.24)30.88 (21.93-39.83)Mean BPa,b=130
73.80 (66.18-81.42)20.40 (13.06-27.74)Mean BP=145
49.86 (40.45-59.27)11.26 (4.90-1762)Mean BP=160
This patient needs to change their medication
21.70 (13.47-29.93)82.26 (75.85-88.67)Mean BP=130
27.32 (19.41-35.23)85.78 (79.37-92.19)Mean BP=145
45.50 (35.72-55.28)90.80 (84.15-97.45)Mean BP=160
aBP: blood pressure.
bAll BPs provided in mm HG.
Table 5. Results of Study 2—risk perception and recall.
Decreasing, mean (95% CI)Increasing, mean (95% CI)Perceived likelihood of the following events
(1 “Extremely Unlikely”-10 “Extremely Likely)
Heart attack in the next 10 years
3.02 (2.42-3.62)7.18 (6.58-7.78)Mean BPa,b=130
3.66 (3.01-4.31)7.96 (7.39-8.53)Mean BP=145
5.60 (4.89-6.31)9.00 (8.56-9.44)Mean BP=160
Stroke in the next 10 years
2.96 (2.34-3.58)7.18 (6.55-7.81)Mean BP=130
3.60 (2.98-4.22)7.98 (7.38-8.58)Mean BP=145
5.56 (4.80-6.32)9.08 (8.60-9.56)Mean BP=160
% of systolic blood pressure points out of range (0%-100%)
4040Mean BP=130 (Actual)>
29.4 (21.45-37.35)56.48 (49.30-63.66)Mean BP=130 (Estimate)
6060Mean BP=145 (Actual)
44.82 (37.15-52.49)63.86 (56.89-70.83)Mean BP=145 (Estimate)
9090Mean BP=160 (Actual)
61.78 (52.23-71.33)84.66 (78.94-90.38)Mean BP=160 (Estimate)
aBP: blood pressure.
bAll BPs provided in mm HG.
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Figure 3. Error in the systolic blood pressure recall—Study 2, mean (large black dot) 95% CI.
Table 6. Results of Study 3— blood pressure control.
2 Down, mean
(95% CI)
2 Up, mean
(95% CI)
1 Down, mean
(95% CI)
1 Up, mean
(95% CI)
Uniform, mean
(95% CI)
Level of agreement with the following statements
(0 “Strongly Disagree”-100 “Strongly Agree”)
This patient’s blood pressure is well controlled
47.02 (38.60-
55.44)
53.07 (44.47-
61.68)
67.71 (59.49-
75.93)
68.91 (61.41-
76.41)
89.22 (84.12-
94.32)
Mean BPa,b =130
19.09 (11.84-
26.34)
39.27 (30.43-
48.12)
28.49 (20.33-
36.65)
40.65 (32.40-
48.91)
37.04 (28.15-
45.92)
Mean BP=145
This patient needs to change their medication
53.98 (46.44-
61.52)
49.87 (40.89-
58.85)
32.47 (24.61-
40.33)
33.18 (24.89-
41.48)
20.87 (12.67-
29.07)
Mean BP=130
84.51 (77.91-
91.11)
73.25 (65.42-
81.09)
76.93 (69.52-
84.34)
65.04 (56.26-
73.81)
70.93 (62.51-
79.35)
Mean BP=145
aBP: blood pressure.
bAll BPs provided in mm HG.
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Table 7. Results of Study 3—risk perception and recall.
2 Down, mean
(95% CI)
2 Up, mean
(95% CI)
1 Down, mean
(95% CI)
1 Up, mean
(95% CI)
Uniform, mean
(95% CI)
Perceived likelihood of the following events
(1 “Extremely Unlikely”-10 “Extremely Likely”)
Heart attack in the next 10 years
4.85 (4.22-5.49)5.29 (4.57-6.01)3.87 (3.28-4.46)4.02 (3.32-4.72)2.65 (2.12-3.19)Mean BPa,b=130
7.69 (7.11-8.27)6.82 (6.10-7.54)7.07 (6.48-7.66)6.24 (5.63-6.84)6.42 (5.75-7.08)Mean BP=145
Stroke in the next 10 years
4.76 (4.06-5.46)5.46 (4.69-6.23)3.90 (3.24-4.56)4.14 (3.40-4.88)2.58 (2.08-3.08)Mean BP=130
7.98 (7.39-8.57)6.95 (6.22-7.67)7.35 (6.73-7.97)6.42 (5.83-7.01)6.55 (5.87-7.22)Mean BP=145
% of systolic blood pressure points out of range (0%-100%)
402030100Mean BP=130 (Actual)
41.58 (33.79-
49.38)
39.47 (31.96-
46.98)
29.27 (21.89-
36.65)
28.80 (20.61-
36.99)
19.58 (11.44-
27.72)
Mean BP=130 (Estimate)
8080806060Mean BP=145 (Actual)
65.91 (58.41-
73.41)
53.18 (45.69-
60.67)
61.78 (54.28-
69.29)
54.09 (46.88-
61.31)
59.33 (51.92-
66.74)
Mean BP=145 (Estimate)
aBP: blood pressure.
bAll BPs provided in mm HG.
Figure 4. Error in the systolic blood pressure recall—Study 3, mean (large black dot) 95% CI.
Discussion
Principal Findings
To inform the development of a physician-patient shared data
visualization tool for BP values, we conducted 3 vignette-based
Web studies to understand better how patients interpret the
variability in visualizations of BP data. In all studies, we
observed that patients with hypertension consistently judged
variations in BP data as meaningful indicators of hypertension
control. In Study 1, increased variability in SBP data was
associated with increasingly negative judgments about
hypertension control, even when the mean SBP remained
constant and within goal range. In Study 2, we demonstrated
that the pattern of change in SBP values over time also
significantly influenced judgments about hypertension control.
While graphs depicting an increase in the SBP over time were
appropriately judged to be of greater concern than graphs
showing a decrease in the SBP over time, recall for the number
of out-of-range BP values was inaccurate. When the SBP values
increased over time, patients remembered more out-of-range
values than when the slope decreased, even though the number
of out-of-range values did not differ in our study. Finally, the
presence of outliers (Study 3) also significantly impacted
patients’ judgments about hypertension control, the need for a
medication change, and the risks associated with uncontrolled
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hypertension. Observing even 1 or 2 outliers in BP data leads
patients to inappropriately determine that hypertension is not
well controlled.
The use of data visualization in electronic medical records has
the potential to transform clinical encounters. While the
technology to develop these tools is available, little is known
about how these data displays will influence patients’ judgments
about hypertension control and subsequent decisions regarding
treatment. These 3 studies have demonstrated that judgments
about hypertension control are strongly and inappropriately
influenced by the presence of outliers and variability in the data.
Outliers and variability mask mean BP values and the presence
of data trends—important predictors of BP-related health
outcomes (eg, heart attack or stroke) [25]. These findings are
important for the development of interventions to promote
shared decision making in primary care, which must direct
attention to clinically meaningful information, that is, mean BP
and trends rather than variability in BP or outliers [25]. It should
be stressed that these conclusions about the potential benefits
of visualization techniques that minimize the impact of outliers
and variability would apply only to measurements obtained
from well-calibrated BP measurement devices. These
recommendations should not be applied to devices where
variability is derived from inaccurate measurement.
Limitations
There are several limitations to these studies that potentially
constrain their generalizability. One limitation is the use of
internet patient samples. When patients are making decisions
about treatment for hypertension, they are typically made in
conjunction with their physician during a clinic visit. In addition,
while our sample of patients is more demographically diverse
than typical internet samples, it is not representative of the
population of patients with hypertension. Furthermore, we
focused only on patients in these studies; therefore, future work
should examine the effect of data visualization on physicians’
judgments about hypertension control, as well as the effect on
shared patient-physician decisions. It is possible that physicians
will perform similarly to patients because we are examining
judgments that stem from common perceptual and cognitive
processes [30,31]. On the other hand, physicians may have
greater knowledge about the relative importance of the BP mean
and variability than patients, which could alter their judgments.
Conclusions
Health information technologies provide an opportunity for
patients to become more engaged in decision making about
hypertension control. We are endeavoring to design a data
visualization tool for BP that can be jointly used by physicians
and patients in this decision-making process. This tool aims to
make the limited time shared in the exam room more efficient
and effective. Defining how data elements, such as trends,
variability, and outliers, support or detract from an
understanding of the data will aid in the design of data
visualizations that highlight meaningful characteristics of the
data; this may, in turn, result in shared decisions that are better
informed. Areas for future study include understanding how
these parameters influence physician judgments about
hypertension control and how information acquisition from data
visualizations is affected by numeracy, health literacy, and graph
literacy of patients and physicians.
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